China Pharma Holdings (CPHI) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 32.39 Mn | 32.22 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.46% |
| Dec 31, 2025 | -87.59% |
| Sep 30, 2025 | -23.30% |
| Jun 30, 2025 | 32.74% |
| Mar 31, 2025 | 35.84% |
| Dec 31, 2024 | -9.53% |
| Sep 30, 2024 | 22.27% |
| Jun 30, 2024 | -50.45% |
| Mar 31, 2024 | 22.42% |
| Dec 31, 2023 | -58.46% |
| Sep 30, 2023 | -31.12% |
| Jun 30, 2023 | -24.59% |
| Mar 31, 2023 | 62.35% |
| Dec 31, 2022 | -59.87% |
| Sep 30, 2022 | 10.99% |
| Jun 30, 2022 | 13.71% |
| Mar 31, 2022 | -4.97% |
| Dec 31, 2021 | -18.64% |
| Sep 30, 2021 | -0.23% |
| Jun 30, 2021 | -7.48% |